An excellent example here are the aggressive triple negative breast cancer tissues which do not express the genes for the most valuable prognostic marker like the estrogen receptor (ER), the progesterone marker (PR) and the human epidermal growth factor receptor type 2 (Her2) [9]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.